e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Pulmonary hypertension: novel insights into the biology of the disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Monosodium urate crystals stimulate IL-6 production via TAK1 and induce pulmonary vascular dysfunction
Laura Moreno (Madrid, Spain), Laura Moreno, Andrea Martínez-Ramas, Bianca Barreira, Rachele Pandolfi, Beatriz De Olaiz Navarro, Daniel Morales-Cano, Raquel Herrero, Jóse ángel Lorente, ángel Cogolludo, Francisco Pérez-Vizcaíno
Source:
International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Session:
Pulmonary hypertension: novel insights into the biology of the disease
Session type:
Thematic Poster Session
Number:
2434
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Laura Moreno (Madrid, Spain), Laura Moreno, Andrea Martínez-Ramas, Bianca Barreira, Rachele Pandolfi, Beatriz De Olaiz Navarro, Daniel Morales-Cano, Raquel Herrero, Jóse ángel Lorente, ángel Cogolludo, Francisco Pérez-Vizcaíno. Monosodium urate crystals stimulate IL-6 production via TAK1 and induce pulmonary vascular dysfunction. Eur Respir J 2015; 46: Suppl. 59, 2434
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Endothelin-1 contributes to the downregulation of BMP/BMPR2 signaling induced by hypoxia
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
HIV-associated pulmonary arterial hypertension onset is associated with the soluble CD14 level and inflammation related to monocyte activation by LPS translocation from the gut
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 915-917
Year: 2014
Corticosteroids inhibit perivascular recruitment of IL-6 producing cells, maintain BMPR-II pulmonary expression and prevent pulmonary hypertension in monocrotalin-exposed rats
Source: Eur Respir J 2007; 30: Suppl. 51, 347s
Year: 2007
MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with
BMPR2
mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats
Source: Eur Respir J 2009; 34: 731
Year: 2009
M2 macrophages derived from patients with idiopathic pulmonary arterial hypertension are susceptible for apelin-mediated suppression of pro-inflammatory cytokines
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension
Source: Eur Respir J 2009; 34: 662
Year: 2009
Uric acid causes excessive pulmonary arterial smooth muscle cell proliferation via URATv1 upregulation in pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Activation of AMPK inhibits pulmonary arterial remodeling
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Sildenafil inhibit dose-dependently profibrotic and remodelling effects of TGFbeta1 on pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
Pulmonary hypertension: the science behind the disease spectrum
Source: Eur Respir Rev 2012; 21: 19-26
Year: 2012
LATE-BREAKING ABSTRACT: TNFalpha mediates ectodomain shedding of BMPR-II: A potential role in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
The interleukin 13 receptor system is altered in pulmonary arterial hypertension
Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept